The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Nanotemper Technologies Inc. for $135,252.00 on September 3, 2020, for characterization of macromolecular interactions. The awardee is a self-certified small disadvantaged business. Work is performed in South San Francisco, California. The order carries a firm fixed price and an ultimate completion date of September 21, 2020. The originating opportunity was posted as a pre-solicitation on August...
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation for $24,545.41 on August 10, 2016. The order procures various laboratory equipment on a firm fixed price basis. Place of performance is Carlsbad, California. The order is scheduled for completion by September 30, 2016.</p>
The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Molecular Devices LLC for $11,339.21 on August 19, 2018. The firm fixed price order, which expired on August 23, 2019, was placed without a set-aside designation. Performance occurred in San Jose, California. The order procured bioanalytical measurement solutions and related scientific equipment from the vendor, a for-profit LLC specializing in advanced laboratory instruments for life science...
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Thermo Electron North America LLC for $11,578.02 on May 31, 2019. The order, classified as a firm fixed-price purchase order with no set-aside designation, obligated funds for scientific instrumentation or laboratory equipment support. Work is performed in Bethesda, Maryland. The order's ultimate completion date was June 4, 2020.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation (operating as Thermo Fisher Scientific) on September 15, 2017, valued at $58,800.00. This modification changed the vendor due to a novation agreement. Performance occurs in Carlsbad, California, with an ultimate completion date of February 28, 2018. The order is firm fixed price with no set-aside applied.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Molecular Devices LLC valued at $2,163.00 on March 31, 2016. The order is a firm fixed price modification to de-obligate expired lines. Place of performance is Sunnyvale, California. The ultimate completion date is April 30, 2016.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. valued at $12,061.94 on November 20, 2019 for instrument relocation services. Place of performance is San Diego, California. The order, issued as a firm fixed-price purchase order with no set-aside designation, de-obligates expired contract lines. The ultimate completion date is December 31, 2019.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation on September 15, 2016, for various laboratory supplies with a firm fixed price of $6,684.06. Performance will occur in Grand Island, New York. The order carries an ultimate completion date of September 19, 2017.</p>
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $12,647 purchase order to Proteinsimple, a division of Bio-Techne Corporation doing business as Bio-Techne, to provide a 12-month service plan. The service plan will be performed at Proteinsimple's location in San Jose, California under firm fixed pricing terms. As part of the National Institutes of Health, NIDDK supports research on diabetes and other endocrine and metabolic diseases; digestive diseases,...
The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Molecular Devices LLC on September 14, 2020, for an ID3 multi-mode microplate detection platform at a ceiling value of $25,000.00. Place of performance is San Jose, California. The order was issued under firm fixed-price terms with an ultimate completion date of September 30, 2020. The procurement was not set-aside and originated from a pre-solicitation opportunity posted on September 13, 2020.